{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,11]],"date-time":"2026-10-11T03:00:41Z","timestamp":1791687641990,"version":"4.3.4"},"reference-count":70,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T00:00:00Z","timestamp":1785801600000},"content-version":"vor","delay-in-days":64,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["8247033457"],"award-info":[{"award-number":["8247033457"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Death Dis"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Benign prostatic hyperplasia (BPH), prevalently in aging men, is characterized by aberrant cell death of prostate cells. Anoikis, a specific subtype of apoptosis, is triggered when cells detach from the extracellular matrix (ECM), in contrast, cells with anoikis resistance contribute to pathological processes such as unregulated cell proliferation and impaired cell death. However, the role of anoikis resistance in BPH pathogenesis remains poorly understood. In this study, an elevated anoikis resistance level was observed in BPH tissues compared to normal prostates. Furthermore, matrix metalloproteinase 7 (MMP7) was identified as a key regulator of anoikis resistance in hyperplastic prostatic epithelium. Under anoikis-inducing conditions, MMP7 promoted mitophagy via the PINK1-Parkin pathway, alleviated mitochondrial stress damage, and enhanced anoikis resistance in BPH-1 cells. Mechanistically, MMP7 interacted with VDAC1 and bound specifically to lysine residues K109 and K110, thereby inhibiting VDAC1 oligomerization and increasing the accumulation of VDAC1 monomers, which served as additional binding sites to Parkin-mediated polyubiquitination. Moreover, clinical data revealed that MMP7 expression levels correlated significantly with the International Prostate Symptom Score (IPSS) and nocturia frequency. Additionally, in vivo experiments demonstrated that inhibition of MMP7 suppressed mitophagy and markedly attenuated prostatic epithelial hyperplasia in a rat model BPH. Collectively, our findings clarify the functional role of the MMP7-VDAC1 axis in BPH pathogenesis and highlight its potential as a therapeutic target for BPH management.<\/jats:p>","DOI":"10.1038\/s41419-026-08867-y","type":"journal-article","created":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T07:16:04Z","timestamp":1780298164000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["MMP7-Triggered mitophagy by regulating parkin-mediated ubiquitination of VDAC1 confers anoikis resistance in the epithelium of hyperplastic prostate"],"prefix":"10.1038","volume":"17","author":[{"given":"Yongying","family":"Zhou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1644-2308","authenticated-orcid":false,"given":"Yan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5604-9047","authenticated-orcid":false,"given":"Huan","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junchao","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jizhang","family":"Qiu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lu","family":"Du","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huan","family":"Lai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ping","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5641-1210","authenticated-orcid":false,"given":"Yuming","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8724-6550","authenticated-orcid":false,"given":"Yongwen","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4754-7794","authenticated-orcid":false,"given":"Michael E.","family":"DiSanto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0267-428X","authenticated-orcid":false,"given":"Xinhua","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,1]]},"reference":[{"key":"8867_CR1","doi-asserted-by":"publisher","DOI":"10.1038\/nrdp.2016.31","volume":"2","author":"B Chughtai","year":"2016","unstructured":"Chughtai B, Forde JC, Thomas DD, Laor L, Hossack T, Woo HH, et al. Benign prostatic hyperplasia. Nat Rev Dis Primers. 2016;2:16031.","journal-title":"Nat Rev Dis Primers"},{"key":"8867_CR2","doi-asserted-by":"publisher","first-page":"576","DOI":"10.1038\/s41391-022-00548-z","volume":"25","author":"HH Woo","year":"2022","unstructured":"Woo HH, Huang CP, Huang WJ, Chang YH, Lien CS, Chkhotua A, et al. The EXPANDER-1 trial: introduction of the novel Urocross Expander System for treatment of lower urinary tract symptoms (LUTS) secondary to benign prostatic hyperplasia (BPH). Prostate Cancer Prostatic Dis. 2022;25:576\u201382.","journal-title":"Prostate Cancer Prostatic Dis"},{"key":"8867_CR3","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1016\/j.jare.2023.04.006","volume":"57","author":"BR Jin","year":"2024","unstructured":"Jin BR, Kim HJ, Na JH, Lee WK, An HJ. Targeting benign prostate hyperplasia treatments: AR\/TGF-beta\/NOX4 inhibition by apocynin suppresses inflammation and proliferation. J Adv Res. 2024;57:135\u201347.","journal-title":"J Adv Res"},{"key":"8867_CR4","doi-asserted-by":"publisher","DOI":"10.1016\/j.redox.2024.103298","volume":"75","author":"M Zhan","year":"2024","unstructured":"Zhan M, Xu H, Yu G, Chen Q, Yang R, Chen Y, et al. Androgen receptor deficiency-induced TUG1 in suppressing ferroptosis to promote benign prostatic hyperplasia through the miR-188-3p\/GPX4 signal pathway. Redox Biol. 2024;75:103298.","journal-title":"Redox Biol"},{"key":"8867_CR5","doi-asserted-by":"publisher","first-page":"1390","DOI":"10.1038\/s42003-024-07071-y","volume":"7","author":"PO Cooper","year":"2024","unstructured":"Cooper PO, Yang J, Wang HH, Broman MM, Jayasundara SM, Sahoo SS, et al. Inflammation impacts androgen receptor signaling in basal prostate stem cells through interleukin 1 receptor antagonist. Commun Biol. 2024;7:1390.","journal-title":"Commun Biol"},{"key":"8867_CR6","doi-asserted-by":"publisher","first-page":"4242","DOI":"10.7150\/ijbs.85739","volume":"19","author":"Y Chen","year":"2023","unstructured":"Chen Y, Xu H, Xu H, Liu C, Zhan M, Wang Z, et al. Exploration of diagnostic biomarkers, microenvironment characteristics, and ursolic acid\u2019s therapeutic effect for benign prostate hyperplasia. Int J Biol Sci. 2023;19:4242\u201358.","journal-title":"Int J Biol Sci"},{"key":"8867_CR7","doi-asserted-by":"publisher","DOI":"10.1002\/mco2.70129","volume":"6","author":"H Liu","year":"2025","unstructured":"Liu H, Zhou Y, Wang Z, Liu D, Li Y, Lai H, et al. Heat Shock Protein Family A Member 1A Attenuates Apoptosis and Oxidative Stress via ERK\/JNK Pathway in Hyperplastic Prostate. MedComm. 2025;6:e70129.","journal-title":"MedComm"},{"key":"8867_CR8","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1186\/s10020-023-00734-2","volume":"29","author":"S Shan","year":"2023","unstructured":"Shan S, Su M, Li Y, Wang Z, Liu D, Zhou Y, et al. Mechanism of RhoA regulating benign prostatic hyperplasia: RhoA-ROCK-beta-catenin signaling axis and static & dynamic dual roles. Mol Med. 2023;29:139.","journal-title":"Mol Med"},{"key":"8867_CR9","doi-asserted-by":"publisher","first-page":"2859","DOI":"10.1073\/pnas.0812666106","volume":"106","author":"P Alonso-Magdalena","year":"2009","unstructured":"Alonso-Magdalena P, Brossner C, Reiner A, Cheng G, Sugiyama N, Warner M, et al. A role for epithelial-mesenchymal transition in the etiology of benign prostatic hyperplasia. Proc Natl Acad Sci USA. 2009;106:2859\u201363.","journal-title":"Proc Natl Acad Sci USA"},{"key":"8867_CR10","doi-asserted-by":"publisher","DOI":"10.1186\/s12967-023-04432-9","volume":"21","author":"Y Li","year":"2023","unstructured":"Li Y, Zhou Y, Liu D, Wang Z, Qiu J, Zhang J, et al. Glutathione Peroxidase 3 induced mitochondria-mediated apoptosis via AMPK \/ERK1\/2 pathway and resisted autophagy-related ferroptosis via AMPK\/mTOR pathway in hyperplastic prostate. J Transl Med. 2023;21:575.","journal-title":"J Transl Med"},{"key":"8867_CR11","doi-asserted-by":"publisher","first-page":"1473","DOI":"10.1038\/sj.cdd.4401723","volume":"12","author":"AP Gilmore","year":"2005","unstructured":"Gilmore AP. Anoikis. Cell Death Differ. 2005;12:1473\u20137.","journal-title":"Cell Death Differ"},{"key":"8867_CR12","doi-asserted-by":"publisher","first-page":"11230","DOI":"10.1158\/0008-5472.CAN-05-2763","volume":"65","author":"G Rennebeck","year":"2005","unstructured":"Rennebeck G, Martelli M, Kyprianou N. Anoikis and survival connections in the tumor microenvironment: is there a role in prostate cancer metastasis?. Cancer Res. 2005;65:11230\u20135.","journal-title":"Cancer Res"},{"key":"8867_CR13","doi-asserted-by":"crossref","unstructured":"Reavis HD, Gysler SM, McKenney GB, Knarr M, Lusk HJ, Rawat P, et al. Norepinephrine induces anoikis resistance in high-grade serous ovarian cancer precursor cells. JCI Insight. 2024;9.e170961.","DOI":"10.1172\/jci.insight.170961"},{"key":"8867_CR14","doi-asserted-by":"publisher","first-page":"7797","DOI":"10.1038\/sj.onc.1205989","volume":"21","author":"TC Windham","year":"2002","unstructured":"Windham TC, Parikh NU, Siwak DR, Summy JM, McConkey DJ, Kraker AJ, et al. Src activation regulates anoikis in human colon tumor cell lines. Oncogene. 2002;21:7797\u2013807.","journal-title":"Oncogene"},{"key":"8867_CR15","doi-asserted-by":"publisher","first-page":"351","DOI":"10.4161\/auto.5523","volume":"4","author":"J Debnath","year":"2008","unstructured":"Debnath J. Detachment-induced autophagy during anoikis and lumen formation in epithelial acini. Autophagy. 2008;4:351\u20133.","journal-title":"Autophagy"},{"key":"8867_CR16","doi-asserted-by":"publisher","DOI":"10.1002\/mco2.718","volume":"5","author":"J Mei","year":"2024","unstructured":"Mei J, Jiang XY, Tian HX, Rong DC, Song JN, Wang L, et al. Anoikis in cell fate, physiopathology, and therapeutic interventions. MedComm. 2024;5:e718. (2020).","journal-title":"MedComm"},{"key":"8867_CR17","doi-asserted-by":"publisher","DOI":"10.1186\/s12964-023-01183-4","volume":"21","author":"Y Dai","year":"2023","unstructured":"Dai Y, Zhang X, Ou Y, Zou L, Zhang D, Yang Q, et al. Anoikis resistance-protagonists of breast cancer cells survive and metastasize after ECM detachment. Cell Commun Signal. 2023;21:190.","journal-title":"Cell Commun Signal"},{"key":"8867_CR18","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1023\/A:1015312119693","volume":"7","author":"J Grossmann","year":"2002","unstructured":"Grossmann J. Molecular mechanisms of \u201cdetachment-induced apoptosis-Anoikis\u201d. Apoptosis. 2002;7:247\u201360.","journal-title":"Apoptosis"},{"key":"8867_CR19","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1002\/path.3000","volume":"226","author":"ML Taddei","year":"2012","unstructured":"Taddei ML, Giannoni E, Fiaschi T, Chiarugi P. Anoikis: an emerging hallmark in health and diseases. J Pathol. 2012;226:380\u201393.","journal-title":"J Pathol"},{"key":"8867_CR20","doi-asserted-by":"publisher","DOI":"10.1016\/j.drup.2024.101099","volume":"75","author":"Y Wang","year":"2024","unstructured":"Wang Y, Cheng S, Fleishman JS, Chen J, Tang H, Chen ZS, et al. Targeting anoikis resistance as a strategy for cancer therapy. Drug Resist Updat. 2024;75:101099.","journal-title":"Drug Resist Updat"},{"key":"8867_CR21","doi-asserted-by":"publisher","DOI":"10.1016\/j.canlet.2025.217750","volume":"624","author":"P Shaw","year":"2025","unstructured":"Shaw P, Dey Bhowmik A, Gopinatha Pillai MS, Robbins N, Dwivedi SKD, Rao G. Anoikis resistance in Cancer: Mechanisms, therapeutic strategies, potential targets, and models for enhanced understanding. Cancer Lett. 2025;624:217750.","journal-title":"Cancer Lett"},{"key":"8867_CR22","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1002\/pros.2990150506","volume":"2","author":"JT Isaacs","year":"1989","unstructured":"Isaacs JT, Coffey DS. Etiology and disease process of benign prostatic hyperplasia. Prostate Suppl. 1989;2:33\u201350.","journal-title":"Prostate Suppl"},{"key":"8867_CR23","doi-asserted-by":"publisher","first-page":"658","DOI":"10.1038\/s41585-020-00396-3","volume":"17","author":"R Tregunna","year":"2020","unstructured":"Tregunna R. Serum MMP7 levels could guide metastatic therapy for prostate cancer. Nat Rev Urol. 2020;17:658.","journal-title":"Nat Rev Urol"},{"key":"8867_CR24","doi-asserted-by":"publisher","first-page":"712","DOI":"10.1124\/pharmrev.121.000349","volume":"74","author":"LGN de Almeida","year":"2022","unstructured":"de Almeida LGN, Thode H, Eslambolchi Y, Chopra S, Young D, Gill S, et al. Matrix Metalloproteinases: From Molecular Mechanisms to Physiology, Pathophysiology, and Pharmacology. Pharmacol Rev. 2022;74:712\u201368.","journal-title":"Pharmacol Rev"},{"key":"8867_CR25","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-44488-1","volume":"15","author":"L Li","year":"2024","unstructured":"Li L, Jiao L, Feng D, Yuan Y, Yang X, Li J, et al. Human apical-out nasal organoids reveal an essential role of matrix metalloproteinases in airway epithelial differentiation. Nat Commun. 2024;15:143.","journal-title":"Nat Commun"},{"key":"8867_CR26","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1016\/j.matbio.2015.03.002","volume":"44-46","author":"MG Rohani","year":"2015","unstructured":"Rohani MG, Parks WC. Matrix remodeling by MMPs during wound repair. Matrix Biol. 2015;44-46:113\u201321.","journal-title":"Matrix Biol"},{"key":"8867_CR27","first-page":"21","volume":"8","author":"B Ke","year":"2017","unstructured":"Ke B, Fan C, Yang L, Fang X. Matrix Metalloproteinases-7 and Kidney Fibrosis. Front Physiol. 2017;8:21.","journal-title":"Front Physiol"},{"key":"8867_CR28","doi-asserted-by":"publisher","first-page":"1399","DOI":"10.1038\/s41388-017-0021-2","volume":"37","author":"B Han","year":"2018","unstructured":"Han B, Zhou B, Qu Y, Gao B, Xu Y, Chung S, et al. FOXC1-induced non-canonical WNT5A-MMP7 signaling regulates invasiveness in triple-negative breast cancer. Oncogene. 2018;37:1399\u2013408.","journal-title":"Oncogene"},{"key":"8867_CR29","doi-asserted-by":"publisher","first-page":"736","DOI":"10.7150\/thno.79876","volume":"13","author":"Y Lu","year":"2023","unstructured":"Lu Y, Li Z, Zhang S, Zhang T, Liu Y, Zhang L. Cellular mitophagy: Mechanism, roles in diseases and small molecule pharmacological regulation. Theranostics. 2023;13:736\u201366.","journal-title":"Theranostics"},{"key":"8867_CR30","doi-asserted-by":"publisher","first-page":"2047","DOI":"10.1038\/s42255-023-00930-8","volume":"5","author":"A Picca","year":"2023","unstructured":"Picca A, Faitg J, Auwerx J, Ferrucci L, D\u2019Amico D. Mitophagy in human health, ageing and disease. Nat Metab. 2023;5:2047\u201361.","journal-title":"Nat Metab"},{"key":"8867_CR31","doi-asserted-by":"publisher","DOI":"10.1016\/j.arr.2022.101817","volume":"84","author":"J Li","year":"2023","unstructured":"Li J, Yang D, Li Z, Zhao M, Wang D, Sun Z, et al. PINK1\/Parkin-mediated mitophagy in neurodegenerative diseases. Ageing Res Rev. 2023;84:101817.","journal-title":"Ageing Res Rev"},{"key":"8867_CR32","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1016\/j.tcb.2016.05.008","volume":"26","author":"TN Nguyen","year":"2016","unstructured":"Nguyen TN, Padman BS, Lazarou M. Deciphering the Molecular Signals of PINK1\/Parkin Mitophagy. Trends Cell Biol. 2016;26:733\u201344.","journal-title":"Trends Cell Biol"},{"key":"8867_CR33","doi-asserted-by":"publisher","first-page":"939","DOI":"10.1038\/cdd.2009.16","volume":"16","author":"J Zhang","year":"2009","unstructured":"Zhang J, Ney PA. Role of BNIP3 and NIX in cell death, autophagy, and mitophagy. Cell Death Differ. 2009;16:939\u201346.","journal-title":"Cell Death Differ"},{"key":"8867_CR34","doi-asserted-by":"publisher","first-page":"1969","DOI":"10.1042\/BST20221364","volume":"52","author":"NM Niemi","year":"2024","unstructured":"Niemi NM, Friedman JR. Coordinating BNIP3\/NIX-mediated mitophagy in space and time. Biochem Soc Trans. 2024;52:1969\u201379.","journal-title":"Biochem Soc Trans"},{"key":"8867_CR35","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-022-04522-4","volume":"13","author":"X Fu","year":"2022","unstructured":"Fu X, Liu J, Liu D, Zhou Y, Guo Y, Wang Z, et al. Glucose-regulated protein 78 modulates cell growth, epithelial-mesenchymal transition, and oxidative stress in the hyperplastic prostate. Cell Death Dis. 2022;13:78.","journal-title":"Cell Death Dis"},{"key":"8867_CR36","doi-asserted-by":"publisher","DOI":"10.1016\/j.redox.2022.102544","volume":"58","author":"T Tian","year":"2022","unstructured":"Tian T, Lu Y, Lin J, Chen M, Qiu H, Zhu W, et al. CPT1A promotes anoikis resistance in esophageal squamous cell carcinoma via redox homeostasis. Redox Biol. 2022;58:102544.","journal-title":"Redox Biol"},{"key":"8867_CR37","doi-asserted-by":"publisher","first-page":"1034","DOI":"10.1038\/nature02765","volume":"430","author":"S Douma","year":"2004","unstructured":"Douma S, Van Laar T, Zevenhoven J, Meuwissen R, Van Garderen E, Peeper DS. Suppression of anoikis and induction of metastasis by the neurotrophic receptor TrkB. Nature. 2004;430:1034\u20139.","journal-title":"Nature"},{"key":"8867_CR38","doi-asserted-by":"publisher","first-page":"7033","DOI":"10.1158\/0008-5472.CAN-05-0709","volume":"65","author":"TR Geiger","year":"2005","unstructured":"Geiger TR, Peeper DS. The neurotrophic receptor TrkB in anoikis resistance and metastasis: a perspective. Cancer Res. 2005;65:7033\u20136.","journal-title":"Cancer Res"},{"key":"8867_CR39","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1016\/j.cell.2010.03.015","volume":"141","author":"K Kessenbrock","year":"2010","unstructured":"Kessenbrock K, Plaks V, Werb Z. Matrix metalloproteinases: regulators of the tumor microenvironment. Cell. 2010;141:52\u201367.","journal-title":"Cell"},{"key":"8867_CR40","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1016\/j.matbio.2015.01.019","volume":"44-46","author":"G Shay","year":"2015","unstructured":"Shay G, Lynch CC, Fingleton B. Moving targets: Emerging roles for MMPs in cancer progression and metastasis. Matrix Biol. 2015;44-46:200\u20136.","journal-title":"Matrix Biol"},{"key":"8867_CR41","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1038\/onc.2016.240","volume":"36","author":"Q Zhang","year":"2017","unstructured":"Zhang Q, Liu S, Parajuli KR, Zhang W, Zhang K, Mo Z, et al. Interleukin-17 promotes prostate cancer via MMP7-induced epithelial-to-mesenchymal transition. Oncogene. 2017;36:687\u201399.","journal-title":"Oncogene"},{"key":"8867_CR42","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1142\/S0192415X20500354","volume":"48","author":"J Wang","year":"2020","unstructured":"Wang J, Cai H, Liu Q, Xia Y, Xing L, Zuo Q, et al. Cinobufacini Inhibits Colon Cancer Invasion and Metastasis via Suppressing Wnt\/beta-Catenin Signaling Pathway and EMT. Am J Chin Med. 2020;48:703\u201318.","journal-title":"Am J Chin Med"},{"key":"8867_CR43","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.1093990","volume":"13","author":"L He","year":"2022","unstructured":"He L, Kang Q, Chan KI, Zhang Y, Zhong Z, Tan W. The immunomodulatory role of matrix metalloproteinases in colitis-associated cancer. Front Immunol. 2022;13:1093990.","journal-title":"Front Immunol"},{"key":"8867_CR44","doi-asserted-by":"publisher","first-page":"825","DOI":"10.3892\/mmr.2014.1897","volume":"9","author":"F Gao","year":"2014","unstructured":"Gao F, Zhang Y, Yang F, Wang P, Wang W, Su Y, et al. Survivin promotes the invasion of human colon carcinoma cells by regulating the expression of MMP\u20117. Mol Med Rep. 2014;9:825\u201330.","journal-title":"Mol Med Rep"},{"key":"8867_CR45","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1038\/s41392-023-01503-7","volume":"8","author":"S Wang","year":"2023","unstructured":"Wang S, Long H, Hou L, Feng B, Ma Z, Wu Y, et al. The mitophagy pathway and its implications in human diseases. Signal Transd Target Ther. 2023;8:304.","journal-title":"Signal Transd Target Ther"},{"key":"8867_CR46","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1080\/15548627.2020.1725377","volume":"17","author":"RQ Yao","year":"2021","unstructured":"Yao RQ, Ren C, Xia ZF, Yao YM. Organelle-specific autophagy in inflammatory diseases: a potential therapeutic target underlying the quality control of multiple organelles. Autophagy. 2021;17:385\u2013401.","journal-title":"Autophagy"},{"key":"8867_CR47","doi-asserted-by":"publisher","first-page":"170","DOI":"10.2174\/1570159X18666200522202319","volume":"19","author":"DM Belousov","year":"2021","unstructured":"Belousov DM, Mikhaylenko EV, Somasundaram SG, Kirkland CE, Aliev G. The Dawn of Mitophagy: What Do We Know by Now?. Curr Neuropharmacol. 2021;19:170\u201392.","journal-title":"Curr Neuropharmacol"},{"key":"8867_CR48","doi-asserted-by":"crossref","unstructured":"Shoshan-Barmatz V, Shteinfer-Kuzmine A, Verma A. VDAC1 at the Intersection of Cell Metabolism, Apoptosis, and Diseases. Biomolecules. 2020;10.1485.","DOI":"10.3390\/biom10111485"},{"key":"8867_CR49","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1038\/ncb2012","volume":"12","author":"S Geisler","year":"2010","unstructured":"Geisler S, Holmstrom KM, Skujat D, Fiesel FC, Rothfuss OC, Kahle PJ, et al. PINK1\/Parkin-mediated mitophagy is dependent on VDAC1 and p62\/SQSTM1. Nat Cell Biol. 2010;12:119\u201331.","journal-title":"Nat Cell Biol"},{"key":"8867_CR50","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-45651-y","volume":"15","author":"AQE Ng","year":"2024","unstructured":"Ng AQE, Chan SN, Pek JW. Nutrient-dependent regulation of a stable intron modulates germline mitochondrial quality control. Nat Commun. 2024;15:1252.","journal-title":"Nat Commun"},{"key":"8867_CR51","doi-asserted-by":"publisher","DOI":"10.1016\/j.neo.2023.100935","volume":"44","author":"J Zhang","year":"2023","unstructured":"Zhang J, Liu L, Li Y, Huang Y, Xiao S, Deng Z, et al. HSP90 C-terminal domain inhibition promotes VDAC1 oligomerization via decreasing K274 mono-ubiquitination in Hepatocellular Carcinoma. Neoplasia. 2023;44:100935.","journal-title":"Neoplasia"},{"key":"8867_CR52","doi-asserted-by":"publisher","first-page":"5698","DOI":"10.1128\/MCB.00165-10","volume":"30","author":"N Keinan","year":"2010","unstructured":"Keinan N, Tyomkin D, Shoshan-Barmatz V. Oligomerization of the mitochondrial protein voltage-dependent anion channel is coupled to the induction of apoptosis. Mol Cell Biol. 2010;30:5698\u2013709.","journal-title":"Mol Cell Biol"},{"key":"8867_CR53","doi-asserted-by":"publisher","first-page":"901","DOI":"10.1083\/jcb.200608073","volume":"175","author":"G Szabadkai","year":"2006","unstructured":"Szabadkai G, Bianchi K, Varnai P, De Stefani D, Wieckowski MR, Cavagna D, et al. Chaperone-mediated coupling of endoplasmic reticulum and mitochondrial Ca2+ channels. J Cell Biol. 2006;175:901\u201311.","journal-title":"J Cell Biol"},{"key":"8867_CR54","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1007\/s13238-015-0144-6","volume":"6","author":"Y Liao","year":"2015","unstructured":"Liao Y, Hao Y, Chen H, He Q, Yuan Z, Cheng J. Mitochondrial calcium uniporter protein MCU is involved in oxidative stress-induced cell death. Protein Cell. 2015;6:434\u201342.","journal-title":"Protein Cell"},{"key":"8867_CR55","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1042\/bj3480343","volume":"348","author":"E Doran","year":"2000","unstructured":"Doran E, Halestrap AP. Cytochrome c release from isolated rat liver mitochondria can occur independently of outer-membrane rupture: possible role of contact sites. Biochem J. 2000;348:343\u201350.","journal-title":"Biochem J"},{"key":"8867_CR56","doi-asserted-by":"publisher","first-page":"4281","DOI":"10.1073\/pnas.1909814117","volume":"117","author":"SJ Ham","year":"2020","unstructured":"Ham SJ, Lee D, Yoo H, Jun K, Shin H, Chung J. Decision between mitophagy and apoptosis by Parkin via VDAC1 ubiquitination. Proc Natl Acad Sci USA. 2020;117:4281\u201391.","journal-title":"Proc Natl Acad Sci USA"},{"key":"8867_CR57","doi-asserted-by":"publisher","first-page":"2443","DOI":"10.1080\/15548627.2023.2182482","volume":"19","author":"Y Liu","year":"2023","unstructured":"Liu Y, Zhang H, Liu Y, Zhang S, Su P, Wang L, et al. Hypoxia-induced GPCPD1 depalmitoylation triggers mitophagy via regulating PRKN-mediated ubiquitination of VDAC1. Autophagy. 2023;19:2443\u201363.","journal-title":"Autophagy"},{"key":"8867_CR58","doi-asserted-by":"crossref","unstructured":"He S, Pan T, Tian R, He Q, Cheng D, Qu H, et al. Fatty acid synthesis promotes mtDNA release via ETS1-mediated oligomerization of VDAC1 facilitating endothelial dysfunction in sepsis-induced lung injury. Cell Death Differ. 2025.32:2177\u201392.","DOI":"10.1038\/s41418-025-01524-5"},{"key":"8867_CR59","doi-asserted-by":"publisher","first-page":"2953","DOI":"10.1021\/jacs.1c09848","volume":"144","author":"EE Najbauer","year":"2022","unstructured":"Najbauer EE, Tekwani Movellan K, Giller K, Benz R, Becker S, Griesinger C, et al. Structure and Gating Behavior of the Human Integral Membrane Protein VDAC1 in a Lipid Bilayer. J Am Chem Soc. 2022;144:2953\u201367.","journal-title":"J Am Chem Soc"},{"key":"8867_CR60","doi-asserted-by":"crossref","unstructured":"Karmi O, Marjault HB, Bai F, Roy S, Sohn YS, Darash Yahana M, et al. A VDAC1-mediated NEET protein chain transfers [2Fe-2S] clusters between the mitochondria and the cytosol and impacts mitochondrial dynamics. Proc Natl Acad Sci USA. 2022;119.e2121491119.","DOI":"10.1073\/pnas.2121491119"},{"key":"8867_CR61","doi-asserted-by":"publisher","first-page":"456","DOI":"10.1161\/CIRCRESAHA.119.315252","volume":"126","author":"Q Hu","year":"2020","unstructured":"Hu Q, Zhang H, Gutierrez Cortes N, Wu D, Wang P, Zhang J, et al. Increased Drp1 Acetylation by Lipid Overload Induces Cardiomyocyte Death and Heart Dysfunction. Circ Res. 2020;126:456\u201370.","journal-title":"Circ Res"},{"key":"8867_CR62","doi-asserted-by":"publisher","first-page":"6215","DOI":"10.1158\/0008-5472.CAN-19-1982","volume":"79","author":"JH Seo","year":"2019","unstructured":"Seo JH, Chae YC, Kossenkov AV, Lee YG, Tang HY, Agarwal E, et al. MFF Regulation of Mitochondrial Cell Death Is a Therapeutic Target in Cancer. Cancer Res. 2019;79:6215\u201326.","journal-title":"Cancer Res"},{"key":"8867_CR63","doi-asserted-by":"publisher","first-page":"13253","DOI":"10.1021\/acs.jmedchem.2c01088","volume":"65","author":"H Tabuse","year":"2022","unstructured":"Tabuse H, Abe-Sato K, Kanazawa H, Yashiro M, Tamura Y, Kamitani M, et al. Discovery of Highly Potent and Selective Matrix Metalloproteinase-7 Inhibitors by Hybridizing the S1\u2019 Subsite Binder with Short Peptides. J Med Chem. 2022;65:13253\u201363.","journal-title":"J Med Chem"},{"key":"8867_CR64","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-022-05162-4","volume":"13","author":"J Li","year":"2022","unstructured":"Li J, Yao H, Huang J, Li C, Zhang Y, Xu R, et al. METTL3 promotes prostatic hyperplasia by regulating PTEN expression in an m(6)A-YTHDF2-dependent manner. Cell Death Dis. 2022;13:723.","journal-title":"Cell Death Dis"},{"key":"8867_CR65","doi-asserted-by":"publisher","first-page":"806","DOI":"10.1097\/JU.0000000000002183","volume":"206","author":"LB Lerner","year":"2021","unstructured":"Lerner LB, McVary KT, Barry MJ, Bixler BR, Dahm P, Das AK, et al. Management of Lower Urinary Tract Symptoms Attributed to Benign Prostatic Hyperplasia: AUA GUIDELINE PART I-Initial Work-up and Medical Management. J Urol. 2021;206:806\u201317.","journal-title":"J Urol"},{"key":"8867_CR66","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1002\/pros.24661","volume":"84","author":"R Jin","year":"2024","unstructured":"Jin R, Forbes CM, Miller NL, Lafin J, Strand DW, Case T, et al. Transcriptomic analysis of benign prostatic hyperplasia identifies critical pathways in prostatic overgrowth and 5-alpha reductase inhibitor resistance. Prostate. 2024;84:441\u201359.","journal-title":"Prostate"},{"key":"8867_CR67","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1007\/s11934-023-01188-z","volume":"24","author":"Z Lin","year":"2023","unstructured":"Lin Z, Liu Z, Niu Y. Exploring the Enigma of 5-ARIs Resistance in Benign Prostatic Hyperplasia: Paving the Path for Personalized Medicine. Curr Urol Rep. 2023;24:579\u201389.","journal-title":"Curr Urol Rep"},{"key":"8867_CR68","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1038\/s41556-018-0034-2","volume":"20","author":"MA Hawk","year":"2018","unstructured":"Hawk MA, Gorsuch CL, Fagan P, Lee C, Kim SE, Hamann JC, et al. RIPK1-mediated induction of mitophagy compromises the viability of extracellular-matrix-detached cells. Nat Cell Biol. 2018;20:272\u201384.","journal-title":"Nat Cell Biol"},{"key":"8867_CR69","doi-asserted-by":"publisher","first-page":"8605","DOI":"10.18632\/aging.103175","volume":"12","author":"H Xiao","year":"2020","unstructured":"Xiao H, Jiang Y, He W, Xu D, Chen P, Liu D, et al. Identification and functional activity of matrix-remodeling associated 5 (MXRA5) in benign hyperplastic prostate. Aging. 2020;12:8605\u201321.","journal-title":"Aging"},{"key":"8867_CR70","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-15913-6","volume":"11","author":"D Liu","year":"2020","unstructured":"Liu D, Shoag JE, Poliak D, Goueli RS, Ravikumar V, Redmond D, et al. Integrative multiplatform molecular profiling of benign prostatic hyperplasia identifies distinct subtypes. Nat Commun. 2020;11:1987.","journal-title":"Nat Commun"}],"container-title":["Cell Death &amp; Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41419-026-08867-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41419-026-08867-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41419-026-08867-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T13:05:30Z","timestamp":1785848730000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41419-026-08867-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,1]]},"references-count":70,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["8867"],"URL":"https:\/\/doi.org\/10.1038\/s41419-026-08867-y","relation":{},"ISSN":["2041-4889"],"issn-type":[{"value":"2041-4889","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,1]]},"assertion":[{"value":"1 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 April 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 May 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 June 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no conflict of interest.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Ethics"}},{"value":"The study was conducted in accordance with the principles of the Declaration of Helsinki. The collection and processing of all human specimens and the collection of patient clinical information were approved by the Medical Ethics Committee of Zhongnan Hospital, Wuhan University, and written informed consent was obtained from the patients or their legal guardians or immediate family members. The study also conformed to the guidelines approved by the Ethics Committee of Zhongnan Hospital, Wuhan University (No. 2021038).","order":2,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Ethics"}}],"article-number":"678"}}